Elan (ELN) Sacked On News from Pfizer (PFE) on Phase 3 Bapineuzumab Study
Go back to Elan (ELN) Sacked On News from Pfizer (PFE) on Phase 3 Bapineuzumab Study| Elan Corp. PLC ADS (NYSE: ELN) | Delayed: 18.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.12 | 52 Week High | $18.21 | |||
| Open | $18.12 | 52 Week Low | $9.37 | |||
| Day High | $18.12 | P/E | N/A | |||
| Day Low | $18.12 | EPS | $0.00 | |||
| Volume | 100 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.25 +0.38 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.87 | 52 Week High | $37.39 | |||
| Open | $27.15 | 52 Week Low | $28.25 | |||
| Day High | $27.40 | P/E | 16.52 | |||
| Day Low | $27.10 | EPS | $1.65 | |||
| Volume | 34,653,268 | |||||
